Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polidocanol injection sclerotherapy for axillary odor
ChiCTR2600132620Phase 4Recruiting
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of 10XB101 in bromhidrosis (BO), sponsored by Shanghai Tenth People's Hospital. Primary endpoint: Proportion of patients with effective improvement in axillary odor symptoms. Started Nov 2025; status: recruiting.
02
Drugs
10XB101
03
Conditions
bromhidrosis (BO)
Beyond the preview
Go deeper on ChiCTR2600132620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600132620.